Drug metabolism and disposition: the biological fate of chemicals

Higher fibroblast growth factor 15 and activating a key metabolism regulator reduce fatty liver disease progression in mice

Updated

Abstract

FGF15 overexpression significantly reduced liver fat accumulation in mice fed a high-fat diet.

  • High-fat diet feeding led to worsened glucose tolerance and increased liver fat in both wild-type and Fgf15 transgenic mice.
  • Fgf15 Tg mice were resistant to weight gain and showed improved glucose tolerance compared to wild-type mice.
  • FGF15 overexpression alone decreased liver injury and lowered the expression of genes related to inflammation and fibrosis.
  • Activation of PPARα, both alone and with FGF15 overexpression, resulted in weight loss and reduced liver fat.
  • The combination of PPARα activation and FGF15 overexpression increased liver injury and inflammation markers, suggesting a complex interaction in MASH.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Conflict of interest The authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free